Brief: Lifecore Biomedical Inc Says Effective May 19 James Hall Resigned As A Co's Director, Ceases CEO Role
May 22 (Reuters) - Lifecore Biomedical Inc LFCR.O :
* LIFECORE BIOMEDICAL INC - EFFECTIVE MAY 19 JAMES G. HALL
RESIGNED AS A DIRECTOR OF CO, CEASED SERVING AS CO'S PRESIDENT
AND CHIEF EXECUTIVE OFFICER
* LIFECORE BIOMEDICAL INC - ON MAY 20 PAUL JOSEPHS BEGAN
SERVING
AS CO'S PRESIDENT AND CHIEF EXECUTIVE OFFICER
Further company coverage: LFCR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lifecore Biomedical
See all newsNASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:40 AM
Lifecore Biomedical, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Lifecore Biomedical Reports Financial Results
Lifecore Biomedical Inc expected to post a loss of 22 cents a share - Earnings Preview